Literature DB >> 2663476

Acromegaly. Diagnosis and therapy.

A L Barkan1.   

Abstract

Acromegaly may be due to various pathologic processes, but the majority of patients harbor a GH-producing pituitary tumor. Careful clinical, biochemical, and radiologic assessment is needed before designing an appropriate therapeutic plan. Treatment options include surgery, irradiation, dopamine agonists, and somatostatin analogues. Indications, limitations, and side effects of each modality are discussed.

Entities:  

Mesh:

Year:  1989        PMID: 2663476

Source DB:  PubMed          Journal:  Endocrinol Metab Clin North Am        ISSN: 0889-8529            Impact factor:   4.741


  11 in total

1.  Hand and foot abnormalities associated with genetic diseases.

Authors:  Henry J Mankin; Jesse Jupiter; Carol Ann Trahan
Journal:  Hand (N Y)       Date:  2010-10-26

2.  Anaesthetic Management of a Case of Acromegaly in Remote Field Location.

Authors:  M Mehrotra; A R Basu
Journal:  Med J Armed Forces India       Date:  2011-07-21

3.  Detection of growth hormone, prolactin and human beta-chorionic gonadotropin messenger RNA in growth-hormone-secreting pituitary adenomas by in situ hybridization.

Authors:  H Uhlig; W Saeger; S Fehr; D K Lüdecke
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1991

4.  Cost of clinical management of acromegaly in Spain.

Authors:  Montse Roset; Sandra Merino-Montero; Manuel Luque-Ramírez; Susan M Webb; Pedro López-Mondéjar; Isabel Salinas; Alfonso Soto; Carmen Bernal; Carlos Villabona; Daniel De Luis; Sergio Donnay; Herminia Pascual; Jesús Pérez-Luis
Journal:  Clin Drug Investig       Date:  2012-04-01       Impact factor: 2.859

Review 5.  Epidemiology of acromegaly.

Authors:  I M Holdaway; C Rajasoorya
Journal:  Pituitary       Date:  1999-06       Impact factor: 4.107

6.  Evaluation of a repeatable depot-bromocriptine preparation(Parlodel LAR) for the treatment of acromegaly.

Authors:  U Plöckinger; H J Quabbe
Journal:  J Endocrinol Invest       Date:  1991-12       Impact factor: 4.256

Review 7.  Clinical pharmacokinetics of octreotide. Therapeutic applications in patients with pituitary tumours.

Authors:  P Chanson; J Timsit; A G Harris
Journal:  Clin Pharmacokinet       Date:  1993-11       Impact factor: 6.447

Review 8.  Pharmacological therapy for acromegaly: a critical review.

Authors:  Alex F Muller; Aart Jan Van Der Lely
Journal:  Drugs       Date:  2004       Impact factor: 9.546

Review 9.  Self image and quality of life in acromegaly.

Authors:  Paola Pantanetti; Nicoletta Sonino; Giorgio Arnaldi; Marco Boscaro
Journal:  Pituitary       Date:  2002-01       Impact factor: 4.107

Review 10.  Pituitary tumors. Current concepts in diagnosis and management.

Authors:  D C Aron; J B Tyrrell; C B Wilson
Journal:  West J Med       Date:  1995-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.